Family Medicine · Anaheim, CA
NPI
1346289915
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
1401 S Anaheim Blvd
Anaheim, CA, 92805
Phone (714) 772-9800
Groups this clinician bills Medicare through
Medicare paid, 2024
$6,468
92 services
Medicare patients, 2024
28
Average age 69
Drug cost, 2024
$2.6M
9,520 prescriptions
Company payments, 2025
$7,007
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David Shek was code 99214 (office e&m - established), 61 times for 26 patients. In total David Shek billed 92 services in 11 codes, and Medicare paid $6,468.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-06-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 61 | 26 | $82.80 | $5,051 |
By year: 2022 $13K for 144 services; 2023 $13K for 174 services; 2024 $6,468 for 92 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 14 | 12 | $8.40 | $118 |
Medicare prescription drug claims, 2024
In 2024, the drug David Shek prescribed most often to Medicare patients was Rosuvastatin Calcium, with 421 prescriptions and refills. In total David Shek wrote 9,520 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 421 | 1,158 | 130 | $5,683 |
| Pioglitazone Hcl Generic | 377 | 935 | 98 | $4,479 |
| Amlodipine Besylate Generic | 338 | 899 | 98 | $1,865 |
| Diclofenac Sodium Generic | 277 | 440 | 62 | $325K |
| Icosapent Ethyl Generic | 249 | 528 | 70 | $85K |
| Losartan Potassium Generic | 248 | 661 | 74 | $2,859 |
| Metformin Hcl Generic | 247 | 656 | 73 | $1,542 |
| Simvastatin Generic | 215 | 560 | 59 | $1,917 |
| Irbesartan Generic | 208 | 511 | 66 | $3,885 |
| Vascepa Icosapent Ethyl | 190 | 268 | 48 | $89K |
| Farxiga Dapagliflozin Propanediol | 187 | 282 | 48 | $155K |
| Kerendia Finerenone | 185 | 228 | 31 | $142K |
| Jardiance Empagliflozin | 181 | 255 | 35 | $147K |
| Omeprazole Generic | 158 | 330 | 49 | $1,358 |
| Atorvastatin Calcium Generic | 157 | 436 | 51 | $1,386 |
Brand drugs: 2,767 claims; generic drugs: 6,575 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David Shek $7,007 ($7,007 in general payments such as food, travel and fees) from 28 companies. The largest payer was Amgen Inc. with $1,758.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.